BioHiTech seeks final approval for HEBioT facility

BioHiTech seeks final approval for HEBioT facility

The company announced its subsidiary submitted a final approval application in New York.

Subscribe
February 27, 2019

BioHiTech Global Inc., a waste management technology and services company based in Chestnut Ridge, New York, is seeking final approval to construct a new 72,000-square-foot HEBioT municipal waste processing facility.

The company has announced that its subsidiary, Rensselaer Resource Recovery, LLC, has submitted an application for final approval from the state of New York to construct and operate the HEBioT facility in Rensselaer, New York.

The planned HEBioT development project is located on 23 acres of land in the city of Rensselaer's southern industrial area designated as an Opportunity Zone under the rules established by Congress in the Tax Cuts and Jobs Act of 2017, which encourages private investment in low-income urban and rural communities.

The company received local approval for its development plan in September of 2018. Upon completion, the facility is expected to generate approximately $12 million of high-margin annual revenue, HiBioTech says. The facility uses a patented waste processing system that converts approximately 40 percent of mixed municipal waste into a solid recovered fuel (SRF) approved by the Environmental Protection Agency (EPA) while reducing landfill usage by as much as 80 percent. BioHiTech controls the exclusive U.S. development rights for the patented HEBioT solid waste processing technology developed by Italy-based Entsorgafin S.P.A. in 11 northeastern states and the District of Columbia.

The Rensselaer project will be the second facility launched by BioHiTech in conjunction with New York-based Kinderhook Industries, a private investment firm that manages over $2.0 billion of committed capital. Kinderhook recently contributed $5.5 million dollars in cash and assets to accelerate the growth of BioHiTech's HEBioT business. The company's first HEBioT facility, located in Martinsburg, West Virginia, has completed construction and is expected to generate $7 million in annual revenue.

"We are excited to have taken this last step in the permitting process to move forward with our Rensselaer HEBioT facility project. With the city of Rensselaer having unanimously approved the project in 2018, we are now working with the state of New York to obtain its approval and begin building this important sustainability project,” says Frank E. Celli, CEO of BioHiTech, in a press release. “With our first U.S. HEBioT plant in West Virginia coming online, our Rensselaer project continuing to move forward and several other projects in the planning stage, we have a strong pipeline that we anticipate will add significant high-margin revenue to BioHiTech in the years to come. We look forward to building value for our shareholders and having a positive impact on the environment through the continued roll-out of our cost-effective waste management solutions."